A detailed history of Chicago Partners Investment Group LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 26,504 shares of DVAX stock, worth $275,641. This represents 0.01% of its overall portfolio holdings.

Number of Shares
26,504
Previous 26,916 1.53%
Holding current value
$275,641
Previous $267,000 1.5%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 29, 2025

SELL
$9.36 - $11.36 $3,856 - $4,680
-412 Reduced 1.53%
26,504 $263,000
Q2 2025

Jul 29, 2025

SELL
$9.4 - $12.87 $2,669 - $3,655
-284 Reduced 1.04%
26,916 $267,000
Q1 2025

May 09, 2025

BUY
$12.39 - $14.4 $337,008 - $391,680
27,200 New
27,200 $352,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.32B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Chicago Partners Investment Group LLC Portfolio

Follow Chicago Partners Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Partners Investment Group LLC with notifications on news.